Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
12 participants
OBSERVATIONAL
2017-03-10
2017-03-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Plasmalyte-148 Solution and Blood Coagulation
NCT03168087
A Gray Zone Approach of Rotational Thromboelastometry for Predicting Postoperative Bleeding in Cardiac Surgical Patients
NCT01889732
Heparin Solution and INTEM/HEPTEM Analysis
NCT01522846
Retrograde Autologous Priming and Mannitol for Reducing Hemodilution in Cardiac Surgery
NCT04870073
Effect of Magnesium Sulphate on Coagulation
NCT01032213
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
0% dilution
Blood specimen which was diluted with 0% level using a mixture of 2.7% sorbitol-0.54% mannitol solution
No interventions assigned to this group
10% dilution
Blood specimen which was diluted with 10% level using a mixture of 2.7% sorbitol-0.54% mannitol solution
A mixture of 2.7% sorbitol-0.54% mannitol solution
Venous blood was taken from 12 healthy volunteers and divided into four specimen bottles, which were diluted with different levels (0%, 10%, 20%, and 40%) using a mixture of 2.7% sorbitol-0.54% mannitol solution.
20% dilution
Blood specimen which was diluted with 20% level using a mixture of 2.7% sorbitol-0.54% mannitol solution
A mixture of 2.7% sorbitol-0.54% mannitol solution
Venous blood was taken from 12 healthy volunteers and divided into four specimen bottles, which were diluted with different levels (0%, 10%, 20%, and 40%) using a mixture of 2.7% sorbitol-0.54% mannitol solution.
40% dilution
Blood specimen which was diluted with 40% level using a mixture of 2.7% sorbitol-0.54% mannitol solution
A mixture of 2.7% sorbitol-0.54% mannitol solution
Venous blood was taken from 12 healthy volunteers and divided into four specimen bottles, which were diluted with different levels (0%, 10%, 20%, and 40%) using a mixture of 2.7% sorbitol-0.54% mannitol solution.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
A mixture of 2.7% sorbitol-0.54% mannitol solution
Venous blood was taken from 12 healthy volunteers and divided into four specimen bottles, which were diluted with different levels (0%, 10%, 20%, and 40%) using a mixture of 2.7% sorbitol-0.54% mannitol solution.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age: 20 to 65 years
* Body weight \> 50 kg
* Volunteers who provided informed consent
Exclusion Criteria
* Anticoagulant medication
20 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Bundang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hyo-Seok Na
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hyo-Seok Na, PhD
Role: STUDY_CHAIR
Seoul National University Bundang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B-1703/386-303
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.